(Q34210949)

31 July 2017

title

Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. (English)

1 reference

31 July 2017

1 reference

1 reference

5

Yoshitsugu Miyazaki

1 reference

31 July 2017

7

Shigeru Kohno

1 reference

31 July 2017

2

Hiroto Matsuse

1 reference

31 July 2017

3

Shinya Tomari

1 reference

31 July 2017

4

Yasushi Obase

1 reference

31 July 2017

Chizu Fukushima

1

1 reference

31 July 2017

Terufumi Shimoda

series ordinal

6

1 reference

31 July 2017

publication date

1 June 2003

1 reference

Annals of Allergy, Asthma & Immunology

31 July 2017

published in

1 reference

31 July 2017

volume

90

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

646-651

1 reference

Establishing a therapeutic index for the inhaled corticosteroids: part II. Comparisons of systemic activity and safety among different inhaled corticosteroids

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in peripheral blood of patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Clinical pharmacology of corticosteroids in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Beclomethasone dipropionate aerosol and oropharyngeal candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Influence of aging on candidal growth and adhesion regulatory agents in saliva

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Measuring efficacy and safety of different inhaled corticosteroid preparations☆☆☆★

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

High-dose beclomethasone inhaler in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Candidiasis and dysphonia complicating beclomethasone treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Development of fluticasone propionate and comparison with other inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Transcriptional potencies of inhaled glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Both IgA subclasses are reduced in parotid saliva from patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

Effects of amphotericin B gargles on oral colonization of Candida albicans in asthmatic patients on steroid inhalation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961870-4

7 January 2021

10.1016/S1081-1206(10)61870-4

Identifiers

DOI

1 reference

release_dk3syn6njjfxxcw5w4q27nytxy

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dk3syn6njjfxxcw5w4q27nytxy

24 November 2022

mapped directly with Wikidata item

1 reference